The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer

NCT06623487 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
PET / CT
Neoadjuvant Immunotherapy

Sponsor

Ruijin Hospital